Clinical trial

Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

NCT01794455

Study summary

ClinicalTrials.gov

Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Sertraline Normalized identity: sertraline View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Candesartan Normalized identity: candesartan View linked drug · Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE4

Conditions

Depressionverified · MONDO: depressive disorder

Hypertensionunresolved

Interventions

SertralineDRUG · verified · RxNorm: sertraline

CandesartanDRUG · verified · RxNorm: candesartan

Sponsors & collaborators

Vanderbilt Universitylead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01794455 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.